Mr. Basta has served as our President and Chief Executive Officer and member of our board of directors since September 2015.
Prior to joining Menlo Therapeutics Inc., from 2011 to 2015, Mr. Basta served as CEO of AlterG, Inc. a privately-held medical device company.
From 2002 through 2010, Mr. Basta served as Chief Executive Officer of BioForm Medical, a publicly-listed medical aesthetics company acquired by Merz, and from February 2010 to September 2011 served as Chief Executive Officer of Merz Aesthetics, the successor to BioForm Medical. Mr. Basta led BioForm’s growth from initial product launch to $80 million in annual revenues at the time of its acquisition by Merz, and subsequently led Merz Aesthetics through multiple product launches managing a global business unit which was the #3 worldwide injectable aesthetics business.
Prior to Bioform Medical, Mr. Basta served as President and CEO of Gliatech, Inc., a medical device company, VP Business Development and Chief Financial Officer of Creative BioMolecules, Inc., a protein therapy and drug device combination products company, and Executive Director of Product Development for The Immune Response Corporation, a biotechnology company.
Mr. Basta is currently a board member of the publicly listed company, Viveve Medical (since September 2018) and serves as Chairman of the Board of Viveve (since January 2019). Mr. Basta previously served on the board of Carbylan from September 2009 to November 2016. Mr. Basta served on the board of RF Surgical (acquired by Medtronic) from December 2013 to August 2015.
Mr. Basta received his M.B.A. from the Kellogg Graduate School of Business at Northwestern University, and his B.A. in biomedical engineering from The Johns Hopkins University.